Biomerics
Focus: Biomerics is a medical device design and manufacturing company headquartered in Costa Rica, specializing in neurology-focused therapeutic devices. The company is in early-stage development with a single active clinical program.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Open Jobs
41+16 this month
Growing — net +16 jobs in 30d
41 jobs added vs 25 removed. Steady team buildout.
Should You Work at Biomerics?
AI assessmentBest suited for early-career engineers seeking hands-on device development experience; significant execution risk given limited pipeline visibility and private status.
Why Work Here
- Engineering-heavy hiring (8 open roles) signals active product development and design focus
- Neurology specialization offers niche therapeutic expertise in a high-value market segment
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Piranha Treatment
Early Development
Single active program indicates company is pre-revenue or early-stage commercialization.
Pipeline & Clinical Trials
Piranha Treatment
Esophageal Food ImpactionHelp build intelligence for Biomerics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.